Peer Reviewed Scientific Publications
A curated collection of our latest peer-reviewed research and scientific contributions.
Journals We Have Published In
Latest Publications
- Systematic and quantitative analyses of hollow fiber model of Mycobacterium abscessus lung disease studies and new dosing recommendations April 21, 2026
- Novel regimens for treatment of Mycobacterium avium lung disease based on advanced in vitro systems and the mathematics of basis functions March 31, 2026
- Rifamycin-, macrolide-, and ethambutol-free combinations to treat Mycobacterium avium complex lung disease February 27, 2026
- Preclinical pharmacokinetics/pharmacodynamics studies defining the role of ethambutol in Mycobacterium kansasii lung disease February 1, 2026
- Pharmacodynamic evidence for tedizolid use in Mycobacterium avium lung disease January 9, 2026
- Eravacycline pharmacokinetics/pharmacodynamics in the hollow fiber system model of Mycobacterium abscessus lung disease January 6, 2026
- Preclinical evaluation of epetraborole in the hollow fibre system model of Mycobacterium abscessus lung disease January 6, 2026
- Tigecycline pharmacodynamics in the hollow fiber system of Mycobacterium avium-complex lung disease and the utility of MICs and time-kill studies in drug development November 12, 2025
- Epetraborole pharmacokinetics/pharmacodynamics in the hollow fiber system model of Mycobacterium tuberculosis November 5, 2025
- Ceftaroline pharmacokinetics/pharmacodynamics in the hollow-fibre model of Mycobacterium abscessus lung disease September 10, 2025
- Sulbactam-durlobactam improves cephalosporin and carbapenem susceptibility and time-kill effect against Mycobacterium abscessus October 7, 2025